Epitizide

• CAT Number: R055375
• CAS Number: 1764-85-8
• Molecular Formula: C10H11ClF3N3O4S3
• Molecular Weight: 425.86
• Purity: ≥95%
• Synonyms: 6-chloro-1,1-dioxo-3-(2,2,2-trifluoroethylsulfanylmethyl)-3,4-dihydro-2H-1λ6,2,4-benzothiadiazine-7-sulfonamide
• IUPAC Name: 6-chloro-1,1-dioxo-3-(2,2,2-trifluoroethylsulfanylmethyl)-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide
• InChI: InChI=1S/C10H11ClF3N3O4S3/c11-5-1-6-8(2-7(5)23(15,18)19)24(20,21)17-9(16-6)3-22-4-10(12,13)14/h1-2,9,16-17H,3-4H2,(H2,15,18,19)
• InChIKey: RINBGYCKMGDWPY-UHFFFAOYSA-N
• SMILES: C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)CSCC(F)(F)F

Epitizide（Cat No.:R055375）is an experimental small molecule that functions as a potent inhibitor of specific enzymes involved in cell signaling and metabolic processes. It is being studied for its potential therapeutic applications in various disease areas, including cancer and metabolic disorders. Epitizide works by modulating key molecular pathways, potentially reducing tumor growth or regulating metabolic dysfunctions. Research is ongoing to determine its precise mechanism of action, efficacy, and safety profile. If successful in clinical trials, Epitizide could become a valuable treatment for diseases driven by abnormal cellular signaling or metabolic imbalance.